Emyria raises A$5m to accelerate drug development and registration programs by Martin Lane November 22, 2021April 29, 2024 Emyria has announced a A$5 million share placement, issuing private investment group Tattarang with 20 million […]
Company news: Cann Group; Releaf Group; Elixinol Wellness; Cronos Australia; Auscann; Zelira; Emyria; Incannex by cannabiz team October 21, 2021April 29, 2024
Emyria selected to join Palantir’s foundry builders program by Martin Lane October 8, 2021April 29, 2024
Company news: Bod Australia; Zelira Therapeutics; Creso Pharma; Emyria; AusCann; Allied Corp by Martin Lane September 23, 2021April 26, 2024
Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea by Martin Lane September 2, 2021April 26, 2024
Company news: Bod; Emyria; Cann Group; Health House; Releaf Clinics; Creso Pharma; Greenfern; Medlab by Martin Lane August 26, 2021April 26, 2024
Cann Group and Emyria go their separate ways on S3 registration by Martin Lane August 13, 2021April 26, 2024
Company news: Emyria; Medibis; Incannex; Eqalis; Greenfern; Creso Pharma; Highlands Investments by Martin Lane August 12, 2021April 26, 2024
Company news: Althea; Lifespot; Emyria; MGC Pharma; Incannex; RotoGro; Clever Leaves by Martin Lane July 28, 2021April 26, 2024
We’re coming for you, TGA warns rule-breaking clinics after issuing 32 cease and desist orders by Steve Jones July 15, 2021April 26, 2024